Decision Diagnos Stock Price, News & Analysis

DECN OTC Link

Company Description

Decision Diagnostics Corp was a California-based medical diagnostics company that developed glucose test strips and smartphone-based electronic medical record technologies. In December 2020, the SEC charged the company and its CEO with securities fraud for making false claims about a COVID-19 blood testing device, leading to criminal charges and the stock's collapse to near-zero value on OTC Markets.

Stock Performance

$—

0.00%

0.00

Last updated:

-

Performance 1 year

$35.8K

141.6M

Shares outstanding

Latest News

December 1, 2020

4.17%

DECN Announces Significant Agreement With Russian Federation Partner for Genviro! and Genviro! Pro COVID-19 Testing Kits as Well as Its Venerable GenUltimate! Blood Glucose Products

covid-19

November 23, 2020

15.83%

DECN XPRIZE Testing Data for Rapid COVID-19 Testing Technology Yields Near Textbook Results

covid-19

November 3, 2020

2.94%

DECN Announces Additional Distribution Agreement With a Distributor and Dealers in Nigeria, Ivory Coast and Lebanon

October 19, 2020

0.00%

DECN Announces Commencement of US-Based Donor Study for FDA EUA Guidance Testing for Their 10.5 Second Genviro! Saliva Swift COVID-19 Test Kits

fda approval covid-19

October 13, 2020

0.00%

DECN Provides Progress Update on Major Events for Its GenViro! Saliva Swift Kits for the Detection of COVID-19

covid-19

October 6, 2020

6.78%

DECN Enters into a New 6 Month $300,000 Promissory Note with Major Current Investor to Help Fund the Recent International Launch if its GenViro! Swift Kits

SEC Filings

No SEC filings available for Decision Diagnos.

Financial Highlights

—

Revenue (TTM)

—

Net Income (TTM)

—

Diluted EPS (TTM)

—

Operating Cash Flow

—

Net Profit Margin

—

Oper. Profit Margin

Upcoming Events

Short Interest History

Last 12 Months

Loading short interest data...

Days to Cover History

Last 12 Months

Loading days to cover data...

Frequently Asked Questions

What is the current stock price of Decision Diagnos (DECN)?

The current stock price of Decision Diagnos (DECN) is $0.000001 as of January 7, 2026.

What is the market cap of Decision Diagnos (DECN)?

The market cap of Decision Diagnos (DECN) is approximately 35.8K. Learn more about what market capitalization means .